Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Imaging-Derived Biomarkers Based On Tridimensional CTA/MRI Hybrid Models For Complex Assessment Of Myocardial Viability After Myocardial Infarction-the HYBRIDHEART Study

NCT04397198 is registered in ClinicalTrials.gov with Cardio Med Medical Center as lead sponsor.

NCT NCT04397198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04397198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Imaging-Derived Biomarkers Based On Tridimensional CTA/MRI Hybrid Models For Complex Assessment Of Myocardial Viability After Myocardial Infarction-the HYBRIDHEART Study
Lead sponsor
Cardio Med Medical Center
Phase
Observational
Overall status
Completed
Start date
July 6, 2020
Completion date
June 1, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, coronary stenosis, myocardial fibrosis, myocardial viability, vulnerable coronary plaques